Results 251 to 256 of about 70,416 (256)

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients

Annals of Oncology, 2013
S Guan, H L Li, D M Fan
exaly  

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

European Journal of Cancer, 2012
Won Young Tak, Ann-Lii Cheng, Dimitris Voliotis   +2 more
exaly  

Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib

International Journal of Cancer, 2013
Bruno CHAUFFERT, Antoine Galmiche, Corinne Godin   +2 more
exaly  

Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma†

Annals of Oncology, 2013
S J Lin, J L Liu, C Xue
exaly  

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

Journal of Hepatology, 2012
Jean-Luc Raoul, Guido Gerken, Peter R Galle   +2 more
exaly  

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040☆

Annals of Oncology
Yoon-Koo Kang, A B El-Khoueiry, B Sangro
exaly